Identification of 3-Oxindole Derivatives as Small Molecule HIV-1 Inhibitors Targeting Tat-Mediated Viral Transcription
Open Access
Abstract
The heterocyclic indole structure has been shown to be one of the most promising scaffolds, offering various medicinal advantages from its wide range of biological activity. Nonetheless, the significance of 3-oxindole has been less known. In this study, a series of novel 3-oxindole-2-carboxylates were synthesized and their antiviral activity against human immunodeficiency virus-1 (HIV-1) infection was evaluated. Among these, methyl (E)-2-(3-chloroallyl)-4,6-dimethyl-one (6f) exhibited the most potent inhibitory effect on HIV-1 infection, with a half-maximal inhibitory concentration (IC50) of 0.4578 μM but without severe cytotoxicity (selectivity index (SI) = 111.37). The inhibitory effect of these compounds on HIV-1 infection was concordant with their inhibitory effect on the viral replication cycle. Mode-of-action studies have shown that these prominent derivatives specifically inhibited the Tat-mediated viral transcription on the HIV-1 LTR promoter instead of reverse transcription or integration. Overall, our findings indicate that 3-oxindole derivatives could be useful as a potent scaffold for the development of a new class of anti-HIV-1 agents.Keywords
Funding Information
- Korea National Institute of Health (KNIH) (2022-NI-006-00, 2020-ER5106-00)
This publication has 25 references indexed in Scilit:
- Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1Journal of Immunological Methods, 2014
- Novel Neuroprotective GSK-3β Inhibitor Restricts Tat-Mediated HIV-1 ReplicationJournal of Virology, 2014
- Novel Cyclopropyl-Indole Derivatives as HIV Non-Nucleoside Reverse Transcriptase InhibitorsACS Medicinal Chemistry Letters, 2012
- Synthesis of a new fluorescent small molecule probe and its use for in vivo lipid imagingChemical Communications, 2011
- New chloro,fluorobenzylindole derivatives as integrase strand-transfer inhibitors (INSTIs) and their mode of actionBioorganic & Medicinal Chemistry, 2010
- New Pyridinone Derivatives as Potent HIV-1 Nonnucleoside Reverse Transcriptase InhibitorsJournal of Medicinal Chemistry, 2009
- Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2Bioorganic & Medicinal Chemistry Letters, 2006
- Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) MonotherapyAntimicrobial Agents and Chemotherapy, 2002
- Diastereoselective Dieckmann condensation suitable for introduction of the duocarmycin A C6 center: Development of a divergent strategy for the total synthesis of duocarmycins A and SABioorganic & Medicinal Chemistry, 1995
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proceedings of the National Academy of Sciences, 1985